Apricus Biosciences Inc news

   Watch this stock
Showing stories 1 - 10 of about 92   

Articles published

APRI 1.27 +0.03 (2.42%)
price chart
Top Growth Pick: Apricus Biosciences, Inc (NASDAQ:APRI)
Apricus Biosciences, Inc (NASDAQ:APRI) has received a top Growth Style score from Zack's Research. The growth score is based on company financials as well as the company's prospects for future growth.
Shares of Apricus Biosciences, Inc (NASDAQ:APRI) Rally 11.77%
Shares of Apricus Biosciences, Inc (NASDAQ:APRI) appreciated by 11.77% during the past week but lost 16.35% on a 4-week basis.
This Week's Pre-Market Outlook: Insignia Systems Inc. (ISIG), Apricus ...  WallStreet Scope
Moving Stocks: Apricus Biosciences (NASDAQ:APRI), The Home Depot (NYSE:HD ...  Stock Transcript
Abnormal volume spikes: Apricus Biosciences Inc (NASDAQ:APR), Transocean ...
Apricus Biosciences Inc (NASDAQ:APR) last session's volume of 719,169.00 shares was higher than its average volume of 128,194.00 shares.
Apricus Biosciences Announces Corporate Update and Second Quarter 2015 ...
(Thomson Reuters ONE via COMTEX) -- SAN DIEGO, July 30, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. APRI, -4.03% a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that the ...
Apricus Biosciences to Present at the Canaccord Genuity 35th Annual Growth ...
5, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Richard Pascoe, Chief Executive Officer, will present at the ...
Will Apricus Biosciences, Inc (NASDAQ:APRI) Beat Analyst Estimates?  Markets Daily
Apricus Biosciences Provides Corporate Update and Second Quarter 2015 ...  Nasdaq
Apricus Biosciences (APRI) in Focus: Stock Jumps 7%
Apricus Biosciences, Inc. (APRI - Snapshot Report) was a big mover last session, as the company saw its shares rise 7% on the day.
Sprout take out stokes Apricus Bio; shares up 11% (APRI)  Seeking Alpha
Momentum Stock in Focus - Apricus Biosciences, Inc (NASDAQ:APRI)
According to Zacks, Apricus Biosciences, Inc (NASDAQ:APRI) has been given a high momentum style score. The score calculation is based on a number of factors indicating that the stock might be at a favorable level to enter a position based on the recent ...
Apricus Biosciences Announces it is Seeking a Global Partner for Femprox, a ...  MarketWatch
Apricus Biosciences Is Executing Its Strategic Plans (APRI)
For the past few years, Apricus Biosciences, Inc. (NASDAQ:APRI) has attempted to turn its trajectory around and focus on a long-term strategy.
Company Shares of Apricus Biosciences, Inc Drops by -9.43%
Apricus Biosciences, Inc (NASDAQ:APRI) has lost 9.43% during the past week and dropped 22.16% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 10.48%.
Why Apricus With Vitaros Intrigues Investors (APRI)
Vitaros, the lead product for the treatment of ED, is a topically-applied cream formulation of alprostadil, a vasodilator and NexACT, which directly increases blood flow to the penis causing an erection.